| 07:00 - 08:15 | 374 | CCC Airway diseases | Challenging clinical cases |
| 07:00 - 08:15 | 375 | CCC Interstitial lung diseases | Challenging clinical cases |
| 07:00 - 08:15 | 376 | CCC Paediatric respiratory diseases | Challenging clinical cases |
| 08:30 - 10:30 | 379 | Interventional pneumology: live out of the box | Endoscopy session |
| 08:30 - 10:30 | 380 | State of the art session: Interstitial lung diseases | Symposium |
| 08:30 - 10:30 | 381 | Multidrug resistance in nosocomial pneumonia: burden, magnitude and solution | Hot topic |
| 08:30 - 10:30 | 382 | Guidelines for long-term management of bronchopulmonary dysplasia in children | Guidelines session |
| 08:30 - 10:30 | 383 | Metabolic alterations in lung ageing and disease | Symposium |
| 08:30 - 10:30 | 384 | Infections, the microbiome and host defence peptides in the development and progression of asthma | Hot topic |
| 08:30 - 10:30 | 385 | Rare lung diseases | Symposium |
| 08:30 - 10:30 | 386 | Respiratory infections? | Lungs on fire |
| 08:30 - 10:30 | 387 | Blood eosinophils and more in airway diseases | Oral Presentation |
| 08:30 - 10:30 | 388 | Exercise physiopathology in various respiratory diseases | Oral Presentation |
| 08:30 - 10:30 | 389 | Best abstracts in pulmonary rehabilitation and chronic care | Oral Presentation |
| 08:30 - 10:30 | 390 | Basic research of airway diseases | Oral Presentation |
| 08:30 - 10:30 | 391 | Cellular metabolism and immune senescence in lung pathology | Oral Presentation |
| 08:30 - 10:30 | 392 | Connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis: what’s new? | Oral Presentation |
| 08:30 - 10:30 | 393 | Molecular and experimental paediatric lung disease | Oral Presentation |
| 08:30 - 10:30 | 395 | Paediatric tuberculosis | Poster Discussion |
| 08:30 - 10:30 | 396 | Pulmonary embolism: from diagnosis to prognosis and treatment | Poster Discussion |
| 08:30 - 10:30 | 397 | Biology of lung cancer | Poster Discussion |
| 08:30 - 10:30 | 398 | Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases | Poster Discussion |
| 08:30 - 10:30 | 399 | Hot topics in noninvasive ventilation | Poster Discussion |
| 08:30 - 10:30 | 400 | Asthma treatment: novel insights from clinical studies | Poster Discussion |
| 10:45 - 12:45 | 406 | Interventional pneumology: live out of the box round two | Endoscopy session |
| 10:45 - 12:45 | 407 | State of the art session: Paediatric respiratory diseases | Symposium |
| 10:45 - 12:45 | 408 | The future of respiratory diseases: what prevention can do | Symposium |
| 10:45 - 12:45 | 409 | Recent clinical advances in inhalation therapy | Symposium |
| 10:45 - 12:45 | 410 | Lung vessels in COPD: it is time to take them seriously! | Symposium |
| 10:45 - 12:45 | 411 | ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Asthma | Clinical trials session |
| 10:45 - 12:45 | 412 | Lumping and splitting of fibrotic interstitial lung diseases | Symposium |
| 10:45 - 12:45 | 413 | Sleep and breathing disorders & Respiratory critical care | Lungs on fire |
| 10:45 - 12:45 | 414 | How do big data and classical epidemiology contribute to solving chronic respiratory ill health? | Symposium |
| 10:45 - 12:45 | 415 | All aspects of general thoracic surgery | Oral Presentation |
| 10:45 - 12:45 | 416 | Brain Metastasis and Malignant pleural effusion: improving our understanding | Oral Presentation |
| 10:45 - 12:45 | 417 | Precision meets immunology in treatment of airway diseases | Oral Presentation |
| 10:45 - 12:45 | 418 | A fresh view on assessment of functional status in COPD | Oral Presentation |
| 10:45 - 12:45 | 419 | Tuberculosis and non-TB mycobacterial infection I | Oral Presentation |
| 10:45 - 12:45 | 420 | Current trends in noninvasive ventilation for chronic respiratory failure | Oral Presentation |
| 10:45 - 12:45 | 421 | Pleural infection and complicated pneumonia | Poster Discussion |
| 10:45 - 12:45 | 422 | Cellular responses and cell therapy in lung injury and repair | Poster Discussion |
| 10:45 - 12:45 | 423 | Advances in asthma pharmacology | Poster Discussion |
| 10:45 - 12:45 | 424 | Advances in clinical management of COPD | Poster Discussion |
| 10:45 - 12:45 | 425 | Insights into physiological diagnostic services | Poster Discussion |
| 10:45 - 12:45 | 426 | Lung function and respiratory muscle testing | Poster Discussion |
| 12:50 - 14:40 | 431 | Pulmonary hypertension: new therapeutic pathways and modalities | Thematic Poster |
| 12:50 - 14:40 | 432 | Innovations in care for chronic respiratory conditions | Thematic Poster |
| 12:50 - 14:40 | 433 | Novel interventions and models of pulmonary rehabilitation | Thematic Poster |
| 12:50 - 14:40 | 434 | Innovations in primary care assessment and management | Thematic Poster |
| 12:50 - 14:40 | 435 | Recent developments in intensive care unit medicine | Thematic Poster |
| 12:50 - 14:40 | 436 | New strategies to treat respiratory failure | Thematic Poster |
| 12:50 - 14:40 | 437 | New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency | Thematic Poster |
| 12:50 - 14:40 | 438 | Novel insights from in vitro and in vivo models of lung disease | Thematic Poster |
| 12:50 - 14:40 | 439 | Immunopathological mechanisms of lung disease | Thematic Poster |
| 12:50 - 14:40 | 440 | Oxidative stress, hypoxia and microbial exposure in the pathogenesis of pulmonary disease | Thematic Poster |
| 12:50 - 14:40 | 441 | Cardiopulmonary exercise testing | Thematic Poster |
| 12:50 - 14:40 | 442 | Treatment of continuous positive airway pressure and monitoring of its effects | Thematic Poster |
| 12:50 - 14:40 | 443 | Beyond continuous positive airway pressure treatment | Thematic Poster |
| 12:50 - 14:40 | 444 | Inhalers: adherence and preference | Thematic Poster |
| 12:50 - 14:40 | 445 | Airway inflammation: pharmacological mechanisms and novel targets | Thematic Poster |
| 12:50 - 14:40 | 446 | COPD treatment: clinical trials, cohorts and inhaler device studies | Thematic Poster |
| 12:50 - 14:40 | 447 | Asthma: outcomes of clinical trials and cohorts | Thematic Poster |
| 12:50 - 14:40 | 448 | Research and innovation in airway diseases | Thematic Poster |
| 12:50 - 14:40 | 449 | Airway disease-associated exacerbations | Thematic Poster |
| 12:50 - 14:40 | 450 | Comorbidities in COPD and asthma: body composition and diabetes | Thematic Poster |
| 12:50 - 14:40 | 451 | Phenotypes and comorbidities of airway diseases | Thematic Poster |
| 12:50 - 14:40 | 452 | Chronic cough, a1-antitrypsin deficiency and other conditions | Thematic Poster |
| 12:50 - 14:40 | 453 | Modelling and monitoring of airway diseases | Thematic Poster |
| 12:50 - 14:40 | 454 | COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses | Thematic Poster |
| 12:50 - 14:40 | 455 | Epidemiology, genetics, air pollution and sleep | Thematic Poster |
| 12:50 - 14:40 | 456 | More and more COPD | Thematic Poster |
| 12:50 - 14:40 | 457 | Indoor and outdoor air quality considerations | Thematic Poster |
| 12:50 - 14:40 | 458 | From the epidemiology of tobacco/electronic nicotine delivery system use to control and prevention of tobacco use | Thematic Poster |
| 12:50 - 14:40 | 459 | From tobacco-related comorbidities to tobacco cessation | Thematic Poster |
| 12:50 - 14:40 | 460 | Asthma biomarkers, diagnostics and risk factors | Thematic Poster |
| 12:50 - 14:40 | 461 | Treatments, adherence and psychosocial aspects of cystic fibrosis | Thematic Poster |
| 12:50 - 14:40 | 462 | Prognosis in bacterial and viral pneumonia | Thematic Poster |
| 12:50 - 14:40 | 463 | Clinical challenges in respiratory infection | Thematic Poster |
| 12:50 - 14:40 | 464 | Complex respiratory infections in clinical practice | Thematic Poster |
| 12:50 - 14:40 | 465 | Tuberculosis: from basic science to patient care | Thematic Poster |
| 12:50 - 14:40 | 466 | Tuberculosis: a public health approach | Thematic Poster |
| 12:50 - 14:40 | 467 | Tuberculosis and non-TB mycobacterial infection II | Thematic Poster |
| 12:50 - 14:40 | 468 | Symptoms, risks, complications and palliative care in thoracic oncology | Thematic Poster |
| 12:50 - 14:40 | 469 | Thoracic oncology: Treatment, diagnostic options and biology | Thematic Poster |
| 12:50 - 14:40 | 470 | Biomarkers of idiopathic interstitial pneumonia | Thematic Poster |
| 12:50 - 14:40 | 471 | Interstitial lung disease registries | Thematic Poster |
| 12:50 - 14:40 | 472 | Assessment and management of immune-mediated interstitial lung diseases | Thematic Poster |
| 12:50 - 14:40 | 473 | Pulmonary hypertension: clinical | Thematic Poster |
| 12:50 - 14:40 | 474 | Interventional pulmonology: endobronchial ultrasound-transbronchial needle aspiration | Thematic Poster |
| 12:50 - 14:40 | 475 | Interventional pulmonology: diagnostic techniques and obstructive airway disease | Thematic Poster |
| 12:50 - 14:40 | 476 | Imaging for prognostication and disease characterisation: 2019 update | Thematic Poster |
| 12:50 - 14:40 | 477 | Use of thoracic ultrasound to diagnose lung diseases | Thematic Poster |
| 13:00 - 14:30 | 478 | Advances in chronic obstructive pulmonary disease and asthma | Lunchtime session |
| 13:00 - 14:30 | 480 | Global burden of respiratory disease and tobacco: an update | Lunchtime session |
| 13:00 - 14:00 | 481 | ME7 Bronchiolitis: is there still much to be discovered? | Meet the expert |
| 13:00 - 14:00 | 483 | ME9 Genetic testing and counselling of patients with rare interstitial lung diseases | Meet the expert |
| 14:45 - 16:45 | 493 | State of the art session: Thoracic oncology | Symposium |
| 14:45 - 16:45 | 494 | Clinical Year in review | Year in review |
| 14:45 - 16:45 | 495 | New clinical practice guidelines for chronic cough | Guidelines session |
| 14:45 - 16:45 | 496 | Occupational and epidemiology Grand Round | Grand round |
| 14:45 - 16:45 | 497 | Pathophysiology and clinical insights into severe non-allergic asthma | Symposium |
| 14:45 - 16:45 | 498 | New perspectives in thoracic surgical oncology | Symposium |
| 14:45 - 16:45 | 499 | High-tech in interstitial lung diseases: just hype and gadgets? | Hot topic |
| 14:45 - 16:45 | 500 | Is your patient dying from air pollution? | Hot topic |
| 14:45 - 16:45 | 501 | Current trends in noninvasive ventilation for acute respiratory failure | Oral Presentation |
| 14:45 - 16:45 | 502 | Insights into the pathophysiology of sleep-disordered breathing | Oral Presentation |
| 14:45 - 16:45 | 503 | Infections, wheezing and asthma in children | Oral Presentation |
| 14:45 - 16:45 | 504 | Advances in bronchiectasis and non-TB mycobacterial infections | Oral Presentation |
| 14:45 - 16:45 | 505 | Novel targets and mechanisms in asthma | Oral Presentation |
| 14:45 - 16:45 | 506 | Effective communication of scientific findings | Symposium |
| 14:45 - 16:45 | 507 | Early origins of respiratory diseases and later life consequences | Oral Presentation |
| 14:45 - 16:45 | 508 | New developments in sleep-disordered breathing, gas exchange and lung function in children | Poster Discussion |
| 14:45 - 16:45 | 509 | Novel findings in paediatric respiratory infections | Poster Discussion |
| 14:45 - 16:45 | 510 | Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD | Poster Discussion |
| 14:45 - 16:45 | 511 | Clinical implications of asthma management | Poster Discussion |
| 14:45 - 16:45 | 512 | Pulmonary hypertension: novelties from the bench | Poster Discussion |
| 14:45 - 16:45 | 513 | Asthma and the world | Poster Discussion |
| 17:15 - 19:15 | 518 | Putting COPD patient needs first: Time for optimizing treatment and device selection | Evening Symposium |